Report cover image

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 194 Pages
SKU # APRC20556292

Description

Summary

According to APO Research, the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Transient Receptor Potential Cation Channel Subfamily V Member 1 market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Transient Receptor Potential Cation Channel Subfamily V Member 1 market include Amgen Inc, Vitality Biopharma Inc, Toray Industries Inc, Sylentis SAU, Pila Pharma AB, Neurim Pharmaceuticals Ltd, Medifron DBT Co Ltd, Kyowa Hakko Kirin Co Ltd and Grunenthal GmbH, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Transient Receptor Potential Cation Channel Subfamily V Member 1, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Transient Receptor Potential Cation Channel Subfamily V Member 1, also provides the value of main regions and countries. Of the upcoming market potential for Transient Receptor Potential Cation Channel Subfamily V Member 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Transient Receptor Potential Cation Channel Subfamily V Member 1 company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Company

Amgen Inc
Vitality Biopharma Inc
Toray Industries Inc
Sylentis SAU
Pila Pharma AB
Neurim Pharmaceuticals Ltd
Medifron DBT Co Ltd
Kyowa Hakko Kirin Co Ltd
Grunenthal GmbH
Flex Pharma Inc
DoNatur GmbH
Daewoong Pharmaceutical Co Ltd
Centrexion Therapeutics Corp
BCN Peptides SA
Amorepacific Corp
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Type

DD-04107
CMX-020
CA-016
Others
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application

Abdominal Pain
Muscle Spasm
Immunology
Pruritus
Ophthalmology
Others
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Transient Receptor Potential Cation Channel Subfamily V Member 1 status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Transient Receptor Potential Cation Channel Subfamily V Member 1 key companies, revenue, market share, and recent developments.
3. To split the Transient Receptor Potential Cation Channel Subfamily V Member 1 breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Transient Receptor Potential Cation Channel Subfamily V Member 1 market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Transient Receptor Potential Cation Channel Subfamily V Member 1 significant trends, drivers, influence factors in global and regions.
6. To analyze Transient Receptor Potential Cation Channel Subfamily V Member 1 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transient Receptor Potential Cation Channel Subfamily V Member 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transient Receptor Potential Cation Channel Subfamily V Member 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transient Receptor Potential Cation Channel Subfamily V Member 1 industry.
Chapter 3: Detailed analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Transient Receptor Potential Cation Channel Subfamily V Member 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Transient Receptor Potential Cation Channel Subfamily V Member 1 in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size, 2020 VS 2024 VS 2031
1.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Dynamics
2.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Drivers
2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Opportunities and Challenges
2.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Restraints
3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Company
3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company Revenue Ranking in 2024
3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2020-2025)
3.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company Ranking (2023-2025)
3.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company Manufacturing Base and Headquarters
3.5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company Product Type and Application
3.6 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Transient Receptor Potential Cation Channel Subfamily V Member 1 Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Type
4.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Type Introduction
4.1.1 DD-04107
4.1.2 CMX-020
4.1.3 CA-016
4.1.4 Others
4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Type
4.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Type (2020-2031)
4.2.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type (2020-2031)
5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Application
5.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Application Introduction
5.1.1 Abdominal Pain
5.1.2 Muscle Spasm
5.1.3 Immunology
5.1.4 Pruritus
5.1.5 Ophthalmology
5.1.6 Others
5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Application
5.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Application (2020-2031)
5.2.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application (2020-2031)
6 Transient Receptor Potential Cation Channel Subfamily V Member 1 Regional Value Analysis
6.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Region (2020-2031)
6.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Region: 2020-2025
6.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value (2020-2031)
6.3.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value (2020-2031)
6.4.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value (2020-2031)
6.5.2 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value (2020-2031)
6.6.2 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value (2020-2031)
6.7.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Country, 2024 VS 2031
7 Transient Receptor Potential Cation Channel Subfamily V Member 1 Country-level Value Analysis
7.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Country (2020-2031)
7.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Country (2020-2025)
7.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.3.2 USA Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.4.2 Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.6.2 Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.7.2 France Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.7.3 France Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.9.2 Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.10.2 Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.11.2 Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.14.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.14.3 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.15.2 Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.17.2 India Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.17.3 India Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.18.2 Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.22.2 Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.24.2 Peru Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.26.2 Israel Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.27.2 UAE Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.29.2 Iran Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Amgen Inc
8.1.1 Amgen Inc Comapny Information
8.1.2 Amgen Inc Business Overview
8.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.1.5 Amgen Inc Recent Developments
8.2 Vitality Biopharma Inc
8.2.1 Vitality Biopharma Inc Comapny Information
8.2.2 Vitality Biopharma Inc Business Overview
8.2.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.2.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.2.5 Vitality Biopharma Inc Recent Developments
8.3 Toray Industries Inc
8.3.1 Toray Industries Inc Comapny Information
8.3.2 Toray Industries Inc Business Overview
8.3.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.3.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.3.5 Toray Industries Inc Recent Developments
8.4 Sylentis SAU
8.4.1 Sylentis SAU Comapny Information
8.4.2 Sylentis SAU Business Overview
8.4.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.4.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.4.5 Sylentis SAU Recent Developments
8.5 Pila Pharma AB
8.5.1 Pila Pharma AB Comapny Information
8.5.2 Pila Pharma AB Business Overview
8.5.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.5.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.5.5 Pila Pharma AB Recent Developments
8.6 Neurim Pharmaceuticals Ltd
8.6.1 Neurim Pharmaceuticals Ltd Comapny Information
8.6.2 Neurim Pharmaceuticals Ltd Business Overview
8.6.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.6.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.6.5 Neurim Pharmaceuticals Ltd Recent Developments
8.7 Medifron DBT Co Ltd
8.7.1 Medifron DBT Co Ltd Comapny Information
8.7.2 Medifron DBT Co Ltd Business Overview
8.7.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.7.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.7.5 Medifron DBT Co Ltd Recent Developments
8.8 Kyowa Hakko Kirin Co Ltd
8.8.1 Kyowa Hakko Kirin Co Ltd Comapny Information
8.8.2 Kyowa Hakko Kirin Co Ltd Business Overview
8.8.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.8.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.8.5 Kyowa Hakko Kirin Co Ltd Recent Developments
8.9 Grunenthal GmbH
8.9.1 Grunenthal GmbH Comapny Information
8.9.2 Grunenthal GmbH Business Overview
8.9.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.9.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.9.5 Grunenthal GmbH Recent Developments
8.10 Flex Pharma Inc
8.10.1 Flex Pharma Inc Comapny Information
8.10.2 Flex Pharma Inc Business Overview
8.10.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.10.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.10.5 Flex Pharma Inc Recent Developments
8.11 DoNatur GmbH
8.11.1 DoNatur GmbH Comapny Information
8.11.2 DoNatur GmbH Business Overview
8.11.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.11.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.11.5 DoNatur GmbH Recent Developments
8.12 Daewoong Pharmaceutical Co Ltd
8.12.1 Daewoong Pharmaceutical Co Ltd Comapny Information
8.12.2 Daewoong Pharmaceutical Co Ltd Business Overview
8.12.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.12.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.12.5 Daewoong Pharmaceutical Co Ltd Recent Developments
8.13 Centrexion Therapeutics Corp
8.13.1 Centrexion Therapeutics Corp Comapny Information
8.13.2 Centrexion Therapeutics Corp Business Overview
8.13.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.13.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.13.5 Centrexion Therapeutics Corp Recent Developments
8.14 BCN Peptides SA
8.14.1 BCN Peptides SA Comapny Information
8.14.2 BCN Peptides SA Business Overview
8.14.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.14.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.14.5 BCN Peptides SA Recent Developments
8.15 Amorepacific Corp
8.15.1 Amorepacific Corp Comapny Information
8.15.2 Amorepacific Corp Business Overview
8.15.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2020-2025)
8.15.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
8.15.5 Amorepacific Corp Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.